Unraveling the correlation between body mass index with CSF Aβ42 and plasma Aβ42 in Alzheimer's disease patients

Key Points

• Increased body mass index correlates with altered levels of CSF Aβ42 and plasma Aβ42 in Alzheimer's disease.
• The study finds that higher body mass index is associated with lower CSF Aβ42 levels, potentially affecting disease progression.
• Analyzed CSF and plasma Aβ42 levels in relation to body mass index among Alzheimer's patients, highlighting significant correlations.
• The findings indicate that body mass index may serve as a useful biomarker in assessing Alzheimer's disease pathology.